PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Anesthesiology, Perioperative, and Pain Medicine Stanford University School of Medicine Stanford CA.\', \'Department of Medicine Stanford University School of Medicine Stanford CA.\', \'Stanford Cancer Institute Stanford University School of Medicine Stanford CA.\', \'Department of Biomedical Data Science Stanford University School of Medicine Stanford CA.\', \'Division of Cardiovascular Medicine The Stanford Prevention Research Center The Cardiovascular Institute Stanford University School of Medicine Stanford CA.\', \'Division of Cardiovascular Medicine University of California San Diego CA.\', \'Division of Cardiology Department of Internal Medicine University of Texas Southwestern Medical Center Dallas TX.\', \'Cardiovascular Division Department of Medicine Brigham and Women\'s HospitalHarvard Medical School Boston MA.\', \'Division of Cardiovascular Medicine University of California San Francisco San Francisco CA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1161/JAHA.121.022913
?:hasPublicationType
?:journal
  • Journal of the American Heart Association
is ?:pmid of
?:pmid
?:pmid
  • 34889112
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.674
?:rankingScore_hIndex
  • 49
is ?:relation_isRelatedTo_publication of
?:title
  • N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID-19 in a Nationwide Hospitalized Cohort.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all